Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03428 | 34002481 | Kaohsiung J Med Sci | Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study. | 2021 | Details |
| A03430 | 34002452 | Obes Rev | Bariatric surgery and the liver-Mechanisms, benefits, and risks. | 2021 | Details |
| A03431 | 34002333 | Diabetes Ther | Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A03432 | 34002097 | Nat Metab | UCP1 governs liver extracellular succinate and inflammatory pathogenesis. | 2021 | Details |
| A03433 | 34002001 | Sci Rep | Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults. | 2021 | Details |
| A03434 | 34001645 | Gut | Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. | 2021 | Details |
| A03435 | 34001034 | BMC Geriatr | Associations between nut intake, cognitive function and non-alcoholic fatty liver disease (NAFLD) in older adults in the United States: NHANES 2011-14. | 2021 | Details |
| A03436 | 34001028 | BMC Gastroenterol | Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study. | 2021 | Details |
| A03437 | 34001005 | BMC Gastroenterol | Association of meat consumption with NAFLD risk and liver-related biochemical indexes in older Chinese: a cross-sectional study. | 2021 | Details |
| A03438 | 34000573 | J Trace Elem Med Biol | Low hepatic manganese concentrations in patients with hepatic steatosis - A cohort study of copper, iron and manganese in liver biopsies. | 2021 | Details |
| A03439 | 34000413 | J Nutr Biochem | PAR2 promotes high-fat diet-induced hepatic steatosis by inhibiting AMPK-mediated autophagy. | 2021 | Details |
| A03440 | 33999818 | IEEE Trans Med Imaging | Non-Invasive Photothermal Strain Imaging of Non-Alcoholic Fatty Liver Disease in Live Animals. | 2021 | Details |
| A03441 | 33999371 | Eat Weight Disord | The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery. | 2021 | Details |
| A03442 | 33998431 | J Dev Orig Health Dis | Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic de novo lipogenesis in offspring. | 2021 | Details |
| A03443 | 33998102 | Hepatol Res | Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma. | 2021 | Details |
| A03444 | 33997821 | STAR Protoc | Comprehensive analysis of liver macrophage composition by flow cytometry and immunofluorescence in murine NASH. | 2021 | Details |
| A03445 | 33996858 | Front Med (Lausanne) | De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study. | 2021 | Details |
| A03446 | 33996143 | J Virus Erad | Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China. | 2021 | Details |
| A03447 | 33995543 | Evid Based Complement Alternat Med | Network Pharmacology-Based Investigation of the Therapeutic Mechanisms of Action of Danning Tablets in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03448 | 33995497 | Front Genet | Bioinformatic Analysis of Crosstalk Between circRNA, miRNA, and Target Gene Network in NAFLD. | 2021 | Details |
| A03449 | 33995425 | Front Immunol | The cGAS-STING Pathway: Novel Perspectives in Liver Diseases. | 2021 | Details |
| A03450 | 33995404 | Front Immunol | Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance. | 2021 | Details |
| A03451 | 33995271 | Front Endocrinol (Lausanne) | Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis. | 2021 | Details |
| A03452 | 33994867 | Int J Biol Sci | MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03453 | 33994854 | Int J Biol Sci | Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver. | 2021 | Details |
| A03454 | 33994708 | J Clin Exp Hepatol | Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. | 2021 | Details |
| A03455 | 33994437 | Intern Med | Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03456 | 33994069 | Cytokine | Changes in liver steatosis in HIV-positive women are associated with the BMI, but not with biomarkers. | 2021 | Details |
| A03457 | 33993872 | Lipids Health Dis | The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population. | 2021 | Details |
| A03458 | 33993608 | Liver Int | Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. | 2021 | Details |
| A03459 | 33993460 | Drugs Real World Outcomes | Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies. | 2021 | Details |
| A03460 | 33992930 | Eur J Med Chem | Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview. | 2021 | Details |
| A03461 | 33992698 | J Hepatol | Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. | 2021 | Details |
| A03462 | 33992651 | Int J Biol Macromol | Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation. | 2021 | Details |
| A03463 | 33992352 | Food Res Int | Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. | 2021 | Details |
| A03464 | 33992322 | Food Res Int | Long-term supplementation with phenolic compounds from jaboticaba (Plinia jaboticaba (Vell.) Berg) reduces adiposophaty and improves glucose, lipid, and energy metabolism. | 2021 | Details |
| A03465 | 33992031 | Semin Liver Dis | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms. | 2021 | Details |
| A03466 | 33991837 | Bioorg Chem | Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis. | 2021 | Details |
| A03467 | 33991635 | J Hepatol | Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. | 2021 | Details |
| A03468 | 33991615 | Cell Signal | Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway. | 2021 | Details |
| A03469 | 33991468 | Biomol Concepts | Myosteatosis in NAFLD patients correlates with plasma Cathepsin D. | 2021 | Details |
| A03470 | 33991461 | Physiol Rep | Prevention of non-alcoholic steatohepatitis by long-term exercise via the induction of phenotypic changes in Kupffer cells of hyperphagic obese mice. | 2021 | Details |
| A03471 | 33991450 | Physiol Rep | Antisense oligonucleotide-mediated knockdown of Mpzl3 attenuates the negative metabolic effects of diet-induced obesity in mice. | 2021 | Details |
| A03472 | 33991395 | Chem Biodivers | The Therapeutic Effects and Mechanisms of Salidroside on Cardiovascular and Metabolic Diseases: An Updated Review. | 2021 | Details |
| A03473 | 33991378 | J Magn Reson Imaging | Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort. | 2021 | Details |
| A03474 | 33990765 | Acta Pharmacol Sin | Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress. | 2021 | Details |
| A03475 | 33990287 | J Med Vasc | Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population. | 2021 | Details |
| A03476 | 33989817 | Cell Mol Gastroenterol Hepatol | Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene. | 2021 | Details |
| A03478 | 33989548 | Cell | Mechanisms and disease consequences of nonalcoholic fatty liver disease. | 2021 | Details |
| A03479 | 33989346 | PLoS One | Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease? | 2021 | Details |
| A03480 | 33988719 | J Mol Cell Biol | Knockdown of insulin-like growth factor 2 gene disrupts mitochondrial functions in the liver. | 2021 | Details |
| A03481 | 33987433 | Ann Transl Med | Exosomes as therapeutic vehicles in liver diseases. | 2021 | Details |
| A03482 | 33987427 | Ann Transl Med | Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention. | 2021 | Details |
| A03483 | 33987425 | Ann Transl Med | Diagnostic management of nonalcoholic fatty liver disease: a transformational period in the development of diagnostic and predictive tools-a narrative review. | 2021 | Details |
| A03484 | 33987424 | Ann Transl Med | Non-alcoholic fatty liver diseases: current challenges and future directions. | 2021 | Details |
| A03485 | 33987359 | Ann Transl Med | ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation. | 2021 | Details |
| A03486 | 33987313 | Ann Transl Med | Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany. | 2021 | Details |
| A03487 | 33987020 | PeerJ | Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study. | 2021 | Details |
| A03488 | 33986604 | Diabetes Metab Syndr Obes | Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A03489 | 33985827 | Ultrasound Med Biol | Diagnostic Performance of 2-D Shear-Wave Elastography with Propagation Maps and Attenuation Imaging in Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03491 | 33985638 | Wei Sheng Yan Jiu | [Mechanism of microRNA-29a regulating steatosis in the human hepatocyte via targeting silent mating type information regulation 2 homolog-1]. | 2021 | Details |
| A03492 | 33984335 | Metabolism | Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy. | 2021 | Details |
| A03493 | 33984334 | Metabolism | A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage. | 2021 | Details |
| A03494 | 33983857 | Viral Immunol | Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis. | 2021 | Details |
| A03495 | 33983444 | Nephrol Dial Transplant | Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus. | 2022 | Details |
| A03496 | 33982943 | Am J Gastroenterol | Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals. | 2021 | Details |
| A03497 | 33982805 | J Ultrasound Med | Reliability of Performing Multiparametric Ultrasound in Adult Livers. | 2021 | Details |
| A03498 | 33982400 | Liver Int | Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 2021 | Details |
| A03499 | 33982243 | Obes Surg | Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study. | 2021 | Details |
| A03500 | 33982065 | J Clin Endocrinol Metab | Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality. | 2021 | Details |
| A03501 | 33980978 | Commun Biol | Sterol O-acyltransferase 2 chaperoned by apolipoprotein J facilitates hepatic lipid accumulation following viral and nutrient stresses. | 2021 | Details |
| A03502 | 33979963 | Zhonghua Gan Zang Bing Za Zhi | [Comparative study of clinicopathological features, and risk factors of advanced fibrosis between genders with non-alcoholic fatty liver disease]. | 2021 | Details |
| A03503 | 33979961 | Zhonghua Gan Zang Bing Za Zhi | [Higher proportion of hepatitis B-related hepatocellular carcinoma combined with metabolic diseases in patients receiving antiviral therapy]. | 2021 | Details |
| A03504 | 33978575 | Clin Liver Dis | The Changing Liver Transplant Recipient: From Hepatitis C to Nonalcoholic Steatohepatitis and Alcohol. | 2021 | Details |
| A03505 | 33978572 | Clin Liver Dis | Obesity Management of Liver Transplant Waitlist Candidates and Recipients. | 2020 | Details |
| A03506 | 33978391 | Minerva Gastroenterol (Torino) | Probiotics and gut health. | 2021 | Details |
| A03507 | 33977953 | Food Funct | Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. | 2021 | Details |
| A03508 | 33977946 | Food Funct | DHA-enriched phosphatidylserine ameliorates non-alcoholic fatty liver disease and intestinal dysbacteriosis in mice induced by a high-fat diet. | 2021 | Details |
| A03509 | 33977096 | Can J Gastroenterol Hepatol | NAFLD and Infection, a Nuanced Relationship. | 2021 | Details |
| A03510 | 33976943 | Int J Hepatol | Emerging Roles of Impaired Autophagy in Fatty Liver Disease and Hepatocellular Carcinoma. | 2021 | Details |
| A03511 | 33975804 | Trends Endocrinol Metab | Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A03512 | 33975381 | Aliment Pharmacol Ther | The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. | 2021 | Details |
| A03513 | 33974978 | Free Radic Biol Med | Effects of astaxanthin in animal models of obesity-associated diseases: A systematic review and meta-analysis. | 2021 | Details |
| A03514 | 33974812 | Annu Rev Biomed Eng | Cell and Tissue Therapy for the Treatment of Chronic Liver Disease. | 2021 | Details |
| A03515 | 33974725 | Phytother Res | Effects of garlic powder supplementation on metabolic syndrome components, insulin resistance, fatty liver index, and appetite in subjects with metabolic syndrome: A randomized clinical trial. | 2021 | Details |
| A03516 | 33973273 | J Gastroenterol Hepatol | Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat. | 2021 | Details |
| A03517 | 33973269 | Hepatology | A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD. | 2021 | Details |
| A03518 | 33973136 | Obes Surg | Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy. | 2021 | Details |
| A03519 | 33972770 | Nat Rev Gastroenterol Hepatol | The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. | 2021 | Details |
| A03520 | 33972568 | Sci Rep | Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway. | 2021 | Details |
| A03521 | 33971822 | BMC Gastroenterol | Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. | 2021 | Details |
| A03522 | 33971815 | BMC Gastroenterol | Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease. | 2021 | Details |
| A03523 | 33970520 | J Magn Reson Imaging | In Vivo Magnetic Resonance Spectroscopy of Hyperpolarized [1-13 C]Pyruvate and Proton Density Fat Fraction in a Guinea Pig Model of Non-Alcoholic Fatty Liver Disease Development After Life-Long Western Diet Consumption. | 2021 | Details |
| A03524 | 33970131 | J Vis Exp | Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH. | 2021 | Details |
| A03525 | 33969426 | Nutr Rev | The interplay of Western diet and binge drinking on the onset, progression, and outlook of liver disease. | 2022 | Details |
| A03526 | 33969054 | World J Clin Cases | Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. | 2021 | Details |
| A03527 | 33967948 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population. | 2021 | Details |
| A03528 | 33967606 | Int J Med Sci | H. pylori is related to NAFLD but only in female: A Cross-sectional Study. | 2021 | Details |
| A03529 | 33967554 | World J Gastroenterol | Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. | 2021 | Details |
| A03530 | 33967185 | Endocr J | Role of chronic inflammation in the pathogenesis of nonalcoholic steatohepatitis: lessons from a unique mouse model using melanocortin receptor-deficient mice. | 2021 | Details |